{"id": "1356761459221532679", "creation": 1612312113.0, "user_id": "65890224", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "This interim analysis of the phase 3 trial of #Russia\u2019s Gam-COVID-Vac (#SputnikV) #vaccine showed 91.6% efficacy against #COVID19 and was well tolerated in a large cohort. (#Lancet, 2 Feb 2021)\n\nSource in comments. https://t.co/Ryh1WAgpai", "first_save": 1634559108.199414, "hashtags": ["#RUSSIA", "#SPUTNIKV", "#VACCINE", "#COVID19", "#LANCET"]}